How To Prepare for a Psilocybin Experience: Science-Backed Advice for a Safe Trip

Psilocybin isn’t just a fringe curiosity anymore. The data is clear: Interest in psilocybin experiences is on the rise as more people broaden their approach to mental healthcare. But whether you’re thinking about having your first psychedelic experience in an attempt to uproot deep-seated traumas, or you just want to rejuvenate your mindset, you need to prioritize safety.

The problem is that most of the information about psilocybin experiences online is anecdotal or unsubstantiated. That's why we’re breaking down the science behind healthy, productive psilocybin experiences, from groundwork to homework.

Understanding Set & Setting

Psilocybin is the psychoactive ingredient in magic mushrooms, colloquially known as shrooms, boomers, or caps. While used recreationally for generations, psilocybin has recently come under the clinical microscope thanks to emergent scientific studies on the drug’s utility in treating conditions like depression or PTSD.

A calm individual sits in a thoughtfully designed room with plants and soft lighting, embodying set and setting principles for psilocybin preparation within a Beckley Retreats psychedelic therapy context.

Inspired by promising findings and the paradigm shift within popular culture,, guided psilocybin experiences offered in retreat programs or clinics are more common than ever. Structured spaces are organized by psychedelic stewards, called facilitators, who often rely on the principles of set & setting to curate the psilocybin experience.

Set: The internal state of the user before and during the experience
Setting: Their external or environmental context while using psilocybin

Set & setting is more than a descriptor of where you’re physically taking psilocybin. It’s a collection of principles meant to make the trip safer and more illuminating. Here’s how.

Cultivating a serene, optimistic perspective prior to ingestion helps “clear the air.”
Establishing goals and desires can provide a navigational aid during the trip.
Maintaining a peaceful environment helps you stay calm and collected while under the effects of psilocybin.

Mental & Emotional Preparation for Psilocybin Experiences

Preparing for a psilocybin experience starts with the mind. Psychedelics like psilocybin alter the mind, allowing for novel experiences which may change beliefs or habits.

A person journaling quietly before a session reflects mental and emotional preparation, a key step in psilocybin preparation and psychedelic therapy at Beckley Retreats, emphasizing intention-setting and self-awareness.

This acute period of neuroplasticity—an increased tendency to form new neural pathways, which some scholars believe may be enhanced by psilocybin—requires you to lay some groundwork in advance if you want to maximize its benefits.

Establish Intention

Psilocybin isn’t a fire-and-forget kind of thing. The mental relationship you have with the drug will affect how you experience its effects. Before the psilocybin experience begins, it pays to establish your intention:

Why am I here?
What do I hope to achieve?
What am I afraid of?

Research tells us that establishing intent is an “important predictor” of the intensity of mystical experiences, especially for those without prior psychedelic experience.

In a retreat setting, facilitators will nudge you through this explorative process during pre-session intake, which can include interviews, talk therapy, journaling, or somatic practices to help you get in touch with your emotions.

Stabilize Your Baseline

You can think of psilocybin like the volume knob on a stereo. It’s not producing the sound per se, but it makes it louder. If you go into a psychedelic experience with a chaotic mindset, you may have a disruptive or even terrifying trip.

A reclining person with eyes closed surrenders to flowing sensations, representing trust and release during psilocybin preparation, guided psychedelic therapy, and supportive set and setting at Beckley Retreats.

That’s why it’s so important to feel calm and steady while preparing for a psilocybin experience. Magic mushrooms aren’t an escape hatch - you need to put out whatever fires are raging within yourself before you can dig into why they started burning in the first place.

Surrender Yourself

Psychedelic experiences are often described as “journeys” rather than “episodes.” You have a part to play in the whole thing, even while navigating an out-of-body experience. As such, it’s crucial to accept that you won’t be fully in the driver’s seat during a psilocybin experience. Acknowledging that in advance can help keep you calm and steer clear of crises during the trip.

Practical Preparation for Psilocybin Experiences

You can perform mental housekeeping until the cows come home, but you have to ingest psilocybin somewhere. This is where practical preparation, or the “setting” part of set & setting, come into play.

Curating the Environment

Psychedelic retreats go the extra mile to provide a safe and serene environment for psilocybin usage, providing everything you need to maximize enjoyment and reduce harm.

A peaceful retreat room with light meals, water, and facilitator support highlights practical psilocybin preparation, emphasizing safe set and setting and structured psychedelic therapy at Beckley Retreats.

If you’re preparing for a psilocybin experience outside of a clinical or retreat setting, you need to take extra steps to make sure the space you’re using is, at minimum, not disruptive to the trip. Prioritize low stimulation: Dim lights, low music, soft surfaces, and familiar objects go a long way.

Nutrition & Hydration

Psilocybin experiences are generally relaxing, but they can affect your body in certain ways. While some evidence suggests no “clear sign” of food affecting how you react to psilocybin, tripping on an empty stomach may be uncomfortable or distracting.

It's generally wise to eat a small, inoffensive meal before your session. You should also have some water beforehand as well as afterward.

Supervision & Stewardship

In the literature, psilocybin use is regarded as psychedelic-assisted therapy, or PAT. The distinction is crucial, as evidence consistently shows facilitators having a positive impact on psilocybin use.

Facilitators are distinct from sitters. The former will generally have experience in psychotherapy, mycology, and use of psychedelics themselves, and observe your session the way a lifeguard monitors a public pool - not to tell you how to swim, but to intervene if necessary.

A tranquil indoor-outdoor space with greenery, soft lighting, and calming elements illustrates curated set and setting, enhancing psilocybin preparation and immersive psychedelic therapy experiences at Beckley Retreats.

It is generally not advisable to prepare for a psilocybin experience alone, much less consume the drug without supervision. If you aren’t working with a retreat or receiving treatment in a clinic, you should at minimum have a sitter president to provide assistance in case of emergency.

Health & Safety Considerations

Psilocybin is a drug, and drugs have side effects. While the data indicate that serious acute adverse effects to psilocybin are “tolerable” and relatively uncommon, you should still pay heed to health & safety considerations while preparing for a psilocybin experience.

Medical screening: Psilocybin can exacerbate conditions like psychosis in some cases. Before consuming psilocybin, you should be aware of contraindications.

Medication issues: Certain pharmaceutical medications may blunt or interfere with psilocybin.

Dosing: Make sure you’re using an appropriate dose of psilocybin. In research settings, acute psilocybin therapy is typically synthetic (lab-grown) and administered between 20 and 30mg.

Planning for Integration

Psilocybin’s residual effects stick around long after the conscious effects - daydreaming, displacement from the body, intense relaxation - wear off. Making use of the emotional material you dredge up on your trip is how people use psilocybin to create long-lasting change.

This process is called integration; a series of practices meant to synthesize insights and solidify new perspectives. In the hours and days after ingesting psilocybin, your brain is primed for integration techniques like talk therapy or journaling.

There are a wide array of integration techniques out there - facilitators know how to direct you toward the ones that will move the needle for you.

Frequently Asked Questions

How do you prepare for a psilocybin experience?

You can prepare for a psilocybin experience by establishing a positive mental outlook and curating your physical environment to be peaceful and predictable during your session.

What is set and setting?

Set and setting describe your psychological and physical status going into a psilocybin experience. You need to take time to make sure they’re peaceful and congruent, as psilocybin tends to amplify whatever emotions are currently present.

Should you take psilocybin alone or with a sitter?

You should always consume psilocybin with a sitter, facilitator, or therapist - especially if it’s your first time. While solo psychedelic journeys are commonplace for experienced users, nobody teaches themselves to swim unassisted.

What should you avoid before taking psilocybin?

Before you take psilocybin, steer clear of stressors - physical, like spicy or upsetting foods, loud music, or excessive screen time, and emotional, like nervousness, anger, or dread. You should also make sure you don’t have any pre-existing conditions, or aren’t taking a drug which may interact negatively, before ingestion.

How long does a psilocybin experience last?

Psilocybin generally ramps up over the course of about 45 minutes. 2 to 3 hours after ingestion, you should reach a “plateau” during your trip, which you’ll then coast through for another few hours.

Psilocybin experiences in retreat settings are multi-day affairs, with days of acclimation prior, and a full day cleared for the session itself, which can last up to 8 hours from start to finish.

Sources

Danias G, Appel J. Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis. JMIR Form Res. 2023 Dec 29;7:e43850. doi: 10.2196/43850. PMID: 38064635; PMCID: PMC10760628.
Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. N Engl J Med. 2022 Nov 3;387(18):1637-1648. doi: 10.1056/NEJMoa2206443. PMID: 36322843.
Khan AJ, Bradley E, O'Donovan A, Woolley J. Psilocybin for Trauma-Related Disorders. Curr Top Behav Neurosci. 2022;56:319-332. doi: 10.1007/7854_2022_366. PMID: 35711024.
Strickland JC, Garcia-Romeu A, Johnson MW. Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy. ACS Pharmacol Transl Sci. 2020 Dec 29;4(2):472-478. doi: 10.1021/acsptsci.0c00187. Erratum in: ACS Pharmacol Transl Sci. 2021 May 21;4(3):1248. doi: 10.1021/acsptsci.1c00119. PMID: 33860177; PMCID: PMC8033606.
Calder, A.E., Hasler, G. Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacol. 48, 104–112 (2023). https://doi.org/10.1038/s41386-022-01389-z
Laird, K. T., Siddarth, P., Ramos, A., Rich, R., Youssef, B., Schwartz, G. M., Sergi, K., Linton, M., Schwartzberg, L., Kelly, D. F., & Heinzerling, K. G. (2026). Intentions, spirituality, set, and setting are associated with mystical experiences in psilocybin-assisted therapy. Journal of Psychedelic Studies.
Otto ME, van der Heijden KV, Schoones JW, van Esdonk MJ, Borghans LGJM, Jacobs GE, van Hasselt JGC. Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis. Clin Pharmacokinet. 2025 Jan;64(1):53-66. doi: 10.1007/s40262-024-01454-4. Epub 2025 Jan 15. Erratum in: Clin Pharmacokinet. 2025 Mar;64(3):465. doi: 10.1007/s40262-025-01487-3. PMID: 39812743; PMCID: PMC11762572.
Villiger D. Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited? Int Rev Psychiatry. 2024 Dec;36(8):869-878. doi: 10.1080/09540261.2024.2357669. Epub 2024 Jun 12. PMID: 39980214; PMCID: PMC11854054.
Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J. Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024 Apr 1;7(4):e245960. doi: 10.1001/jamanetworkopen.2024.5960. PMID: 38598236; PMCID: PMC11007582.
Morris SL. A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient. Clin Psychopharmacol Neurosci. 2024 Nov 30;22(4):684-687. doi: 10.9758/cpn.24.1180. Epub 2024 May 21. PMID: 39420616; PMCID: PMC11494431.
Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen J, Schoevers R. Concomitant use of antidepressants and classic psychedelics: A scoping review. J Psychopharmacol. 2025 Oct;39(10):1072-1088. doi: 10.1177/02698811251368360. Epub 2025 Sep 12. PMID: 40937732; PMCID: PMC12572353.
MacCallum CA, Lo LA, Pistawka CA, Deol JK. Therapeutic use of psilocybin: Practical considerations for dosing and administration. Front Psychiatry. 2022 Dec 1;13:1040217. doi: 10.3389/fpsyt.2022.1040217. PMID: 36532184; PMCID: PMC9751063.
Bathje GJ, Majeski E, Kudowor M. Psychedelic integration: An analysis of the concept and its practice. Front Psychol. 2022 Aug 4;13:824077. doi: 10.3389/fpsyg.2022.824077. PMID: 35992410; PMCID: PMC9386447.